Alfred P. Spada
2015
In 2015, Alfred P. Spada earned a total compensation of $977.3K as Executive Vice President, Research and Development, and Chief Scientific Officer at Conatus Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,586 |
|---|---|
| Option Awards | $475,930 |
| Salary | $373,602 |
| Other | $17,207 |
| Total | $977,325 |
Spada received $475.9K in option awards, accounting for 49% of the total pay in 2015.
Spada also received $110.6K in non-equity incentive plan, $373.6K in salary and $17.2K in other compensation.
Rankings
In 2015, Alfred P. Spada's compensation ranked 8,071st out of 13,638 executives tracked by ExecPay. In other words, Spada earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,071 out of 13,638 | 41st |
Division Manufacturing | 3,070 out of 5,190 | 41st |
Major group Chemicals And Allied Products | 1,111 out of 1,854 | 40th |
Industry group Drugs | 897 out of 1,528 | 41st |
Industry Pharmaceutical Preparations | 702 out of 1,182 | 41st |
Source: SEC filing on April 28, 2016.
Spada's colleagues
We found two more compensation records of executives who worked with Alfred P. Spada at Conatus Pharmaceuticals in 2015.